Published in AIDS Weekly, October 30th, 1995
Several neuropathological studies have concluded that zidovudine treatment reduces the frequency of HIV induced brain lesions in AIDS patients, and may also reduce the incidence of AIDS dementia. The neuroprotective effect of zidovudine, however, has varied with individual studies. In one study brain lesions actually increased in patients treated with zidovudine (Davies et al., Clin Neuropathol 1993,12(suppl 1):9).
In this study, researcher Jan Maehlen and colleagues investigated the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.